CHRONIC HEPATITIS C (CHC)
Clinical trials for CHRONIC HEPATITIS C (CHC) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS C (CHC) trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS C (CHC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis c: experimental drug combo shows promise
Disease control CompletedThis completed Phase 3 trial tested an experimental drug called MP-424, combined with two standard hepatitis C medications (pegylated interferon and ribavirin), in 54 adults with genotype 1 hepatitis C. Participants were either new to treatment or had relapsed after previous ther…
Matched conditions: CHRONIC HEPATITIS C (CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for hepatitis c: triple therapy shows promise in late-stage trial
Disease control CompletedThis study tested a new drug called MP-424 combined with two standard medicines (interferon beta and ribavirin) in 74 adults with chronic hepatitis C (genotype 1 or 2). Participants either had never been treated before or had previously received interferon-based therapy. The main…
Matched conditions: CHRONIC HEPATITIS C (CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC